Inhibition of PRKAA/AMPK (Ser485/491) phosphorylation by crizotinib induces cardiotoxicity via perturbing autophagosome-lysosome fusion
Zhifei Xu(Center for Drug Evaluation and Research), Peihua Luo(Zhejiang Lab)
Cited by 56
Related Papers
A Comprehensive Review of Clinical Cardiotoxicity Incidence of FDA-Approved Small-Molecule Kinase Inhibitors
|Frontiers in Pharmacology|2020|80
Cross‐signaling among phosphinositide‐3 kinase, mitogen‐activated protein kinase and sonic hedgehog pathways exists in esophageal cancer
|International Journal of Cancer|2010|60
s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand–foot skin reaction that can be reversed by nicotinamide
|Cell Research|2020|44
Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK/MDM2/p53 axis
|Nature Communications|2023|39